WEBINAR: Invitrogen Immunoassays: Vast Choice of Appropriate Tools for Specific Needs

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Senior Manager, Research and Development, Antibodies and Immunoassays, Thermo Fisher Scientific
    Biography
      Markus leads the R&D group at the Vienna Center of Excellence for Immunoassay Development at Thermo Fisher Scientific. He is responsible for product and technology development as well as contract and custom lab services. Prior to joining Thermo Fisher Scientific, Markus was head of the laboratory for immunoassay development at Affymetrix and was group leader for immunoassay development at eBioscience. Also, he was project leader of R&D for immunoassay development and establishment of new immunoassay technologies (instant ELISA assay; in-house developed, bead-based multiplexing immunoassay technology) at Bender MedSystems GmbH. Markus holds a master's degree from the University of Vienna (Institute of Biochemistry).

    Abstract:

    Understanding the complex, yet coordinated protein interactions that sustain life, may help unlock the mysteries of disease mechanisms and thereby treatments. Protein identification and quantification have become extremely valuable in advancing our understanding and finding cures. As there are many methodologies available to scientists today, it can be challenging to choose which tools are the most effective to answer specific questions.

    Based on the decades of market experience in the immunological research reagents market, Thermo Fisher Scientific addresses different customer needs by different technologies for detecting the same analytes and offers a vast choice of appropriate tools for the customer’s specific needs.

    Learning Objectives:

    • Identify time-saving technologies and tools for protein quantitation
    • Understand the benefits of choosing from different immunoassay platforms and formats, all from the same provider

    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    Loading Comments...